Johan A Kers Selected Research

Bacteriocins (Lantibiotics)

1/2019	Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of Clostridium difficile-Associated Infection.
1/2018	Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection.
1/2018	OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan A Kers Research Topics

Disease

3	Clostridium Infections 01/2019 - 01/2018
2	Infections 01/2019 - 01/2018
1	Body Weight (Weight, Body) 01/2019
1	Colitis 01/2019
1	Diarrhea 01/2019

Drug/Important Bio-Agent (IBA)

3	Bacteriocins (Lantibiotics)IBA 01/2019 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2018
1	mutacin 1140IBA 01/2018